van Gorp EC - Search Results

1

Markers of inflammation and coagulation indicate a prothrombotic state in HIV-infected patients with long-term use of antiretroviral therapy with or without abacavir.

Jong E, Meijers JC, van Gorp EC, Spek CA, Mulder JW. Jong E, et al. Among authors: van gorp ec. AIDS Res Ther. 2010 Apr 16;7:9. doi: 10.1186/1742-6405-7-9. AIDS Res Ther. 2010. PMID: 20398387 Free PMC article.

2

Discrepancies between medical and pharmacy records for patients on anti-HIV drugs.

de Maat MM, Frankfort SV, Mathôt RA, Mulder JW, Meenhorst PL, van Gorp EC, Koks CH, Hoetelmans RM, de Boer A, Beijnen JH. de Maat MM, et al. Among authors: van gorp ec. Ann Pharmacother. 2002 Mar;36(3):410-5. doi: 10.1345/aph.1A167. Ann Pharmacother. 2002. PMID: 11898804

3

Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals.

De Maat MM, Mathôt RA, Veldkamp AI, Huitma AD, Mulder JW, Meenhorst PL, Van Gorp EC, Carlier H, Beijnen JH. De Maat MM, et al. Among authors: van gorp ec. Pharmacol Res. 2002 Sep;46(3):295-300. doi: 10.1016/s1043-6618(02)00146-9. Pharmacol Res. 2002. PMID: 12220974

4

Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals.

de Maat MM, Huitema AD, Mulder JW, Meenhorst PL, van Gorp EC, Beijnen JH. de Maat MM, et al. Among authors: van gorp ec. Br J Clin Pharmacol. 2002 Oct;54(4):378-85. doi: 10.1046/j.1365-2125.2002.01657.x. Br J Clin Pharmacol. 2002. PMID: 12392585 Free PMC article. Clinical Trial.

5

Subtherapeutic antiretroviral plasma concentrations in routine clinical outpatient HIV care.

de Maat MM, Huitema AD, Mulder JW, Meenhorst PL, van Gorp EC, Mairuhu AT, Beijnen JH. de Maat MM, et al. Among authors: van gorp ec. Ther Drug Monit. 2003 Jun;25(3):367-73. doi: 10.1097/00007691-200306000-00018. Ther Drug Monit. 2003. PMID: 12766566

6

Incidence and risk factors for nevirapine-associated rash.

de Maat MM, ter Heine R, Mulder JW, Meenhorst PL, Mairuhu AT, van Gorp EC, Huitema AD, Beijnen JH. de Maat MM, et al. Among authors: van gorp ec. Eur J Clin Pharmacol. 2003 Sep;59(5-6):457-62. doi: 10.1007/s00228-003-0613-3. Epub 2003 Aug 12. Eur J Clin Pharmacol. 2003. PMID: 12920493

7

Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine-containing antiretroviral treatment.

de Maat MM, ter Heine R, van Gorp EC, Mulder JW, Mairuhu AT, Beijnen JH. de Maat MM, et al. Among authors: van gorp ec. AIDS. 2003 Oct 17;17(15):2209-14. doi: 10.1097/00002030-200310170-00009. AIDS. 2003. PMID: 14523278

8

The plasma and intracellular steady-state pharmacokinetics of lopinavir/ritonavir in HIV-1-infected patients.

Crommentuyn KM, Mulder JW, Mairuhu AT, van Gorp EC, Meenhorst PL, Huitema AD, Beijnen JH. Crommentuyn KM, et al. Among authors: van gorp ec. Antivir Ther. 2004 Oct;9(5):779-85. Antivir Ther. 2004. PMID: 15535416

9

Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients.

Kappelhoff BS, Huitema AD, Crommentuyn KM, Mulder JW, Meenhorst PL, van Gorp EC, Mairuhu AT, Beijnen JH. Kappelhoff BS, et al. Among authors: van gorp ec. Br J Clin Pharmacol. 2005 Feb;59(2):174-82. doi: 10.1111/j.1365-2125.2004.02241.x. Br J Clin Pharmacol. 2005. PMID: 15676039 Free PMC article.

10

Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients.

Kappelhoff BS, Huitema AD, Sankatsing SU, Meenhorst PL, Van Gorp EC, Mulder JW, Prins JM, Beijnen JH. Kappelhoff BS, et al. Among authors: van gorp ec. Br J Clin Pharmacol. 2005 Sep;60(3):276-86. doi: 10.1111/j.1365-2125.2005.02436.x. Br J Clin Pharmacol. 2005. PMID: 16120066 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page